Quality | 2023.06.12
Producing High Quality CRISPR-Cas9 Edited hiPSCs for Cardiac Disease Modeling, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn about the quality criteria for human induced pluripotent stem cells (iPSCs) used for disease modeling experiments. Attendees will learn about quality assessment and validation of human iPSCs after CRISPR editing. The featured speaker will discuss reproducible cardiac differentiation using a stirred suspension bioreactor system. Attendees will learn about methods of in vitro phenotyping using human iPSC-derived cardiomyocytes.
(PRWeb June 12, 2023)
Read the full story at https://www.prweb.com/releases/producing_high_quality_crispr_cas9_edited_hipscs_for_cardiac_disease_modeling_upcoming_webinar_hosted_by_xtalks/prweb19385705.htm
For more information, please visit
https://www.prweb.com/releases/producing[...]ed_by_xtalks/prweb19385705.htm
